Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
89 hedge funds and large institutions have $78.6M invested in Surgalign Holdings, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 15 closing their positions.
609% more call options, than puts
Call options by funds: $319K | Put options by funds: $45K
1% more funds holding
Funds holding: 88 → 89 (+1)
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
13% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 31
46% less capital invested
Capital invested by funds: $145M → $78.6M (-$66.6M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.73M |
| 2 |
Morgan Stanley
New York
|
+$2.13M |
| 3 |
Blackstone Inc
New York
|
+$1.77M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$1.22M |
| 5 |
RA
Royce & Associates
New York
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$12.1M |
| 2 |
HM
HealthCor Management
New York
|
-$6.86M |
| 3 |
HC
Hillman Company
Pittsburgh,
Pennsylvania
|
-$3.44M |
| 4 |
Millennium Management
New York
|
-$911K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$328K |
SRGA Hedge Fund Activity: Q3 2020 in Review
89 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2020, worth a combined $78.6M — down 46% from $145M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new SRGA positions and 15 closed out — a net gain of 1 holder — while 27 added to existing stakes and 31 trimmed.
The largest buyer was Wasatch Advisors, adding an estimated $2.73M. The largest seller was Paradigm Capital Management Inc, cutting an estimated $12.1M.
- 89 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2020, up from 88 in Q2 2020.
- Funds reported $78.6M of Surgalign Holdings, Inc. Common Stock stock for Q3 2020, down 46% quarter-over-quarter.
- 16 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2020 and 15 closed out, a net change of +1 holder.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2020 was Wasatch Advisors, an estimated $2.73M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2020 was Paradigm Capital Management Inc, an estimated $12.1M sold.
Based on aggregated 13F filings for Q3 2020.